ASRT vs TAP
Assertio Therapeutics Inc (ASRT) versus TAP (TAP) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
TAP (TAP) common stock.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
TAP does not have a complete income-statement cache yet.
ASRT currently screens at market cap $151.5M. TAP currently screens at market cap $0.
Not investment advice. Open the ASRT and TAP stock pages for the full models.
Not investment advice.